SCPHARMACEUTICALS INC. Accrued Professional Fees, Current
SCPHARMACEUTICALS INC. had Accrued Professional Fees, Current of $789.00 thousand as of 2025-06-30, per its 10-Q filed 2025-08-07.
Financial Statements › Notes › Accrued Liabilities, Current
us-gaap:AccruedProfessionalFeesCurrent · last filed 2025-08-07
- 2025-06-30: Accrued Professional Fees, Current $789.00K.
- 2025-03-31: Accrued Professional Fees, Current $877.00K.
- 2024-12-31: Accrued Professional Fees, Current $529.00K.
- 2024-09-30: Accrued Professional Fees, Current $658.00K.
| Period end | Accrued Professional Fees, Current |
|---|---|
| 2025-06-30 | $789.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $877.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $529.00K 10-Q · filed 2025-08-07 |
| 2024-09-30 | $658.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $606.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $1.63M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $945.00K 10-K · filed 2025-03-19 |
| 2023-09-30 | $953.00K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $856.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $908.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $603.00K 10-K · filed 2024-03-13 |
| 2022-09-30 | $591.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $386.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $335.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $265.00K 10-K · filed 2023-03-22 |
| 2021-09-30 | $311.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $297.00K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $203.00K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $364.00K 10-K · filed 2022-03-22 |
| 2020-09-30 | $811.00K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $364.00K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $321.00K 10-Q · filed 2020-05-12 |
| 2019-12-31 | $296.00K 10-K · filed 2021-03-23 |
| 2019-09-30 | $338.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $204.00K 10-Q · filed 2019-08-07 |
| 2019-03-31 | $192.00K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $356.00K 10-K · filed 2020-03-24 |
| 2018-09-30 | $251.00K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $275.00K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $950.00K 10-Q · filed 2018-05-07 |
| 2017-12-31 | $287.00K 10-K · filed 2019-03-21 |